Hovione Overview

  • Year Founded
  • 1959

Year Founded

  • Status
  • Private

  • Employees
  • 2,600

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 1

  • Investments
  • 5

Hovione General Information

Description

Operator of a contract drug substance manufacturing company intended for making disease treatment faster and more affordable. The company's services specialize in drug testing, drug molecule screening, and particle engineering, and seeks partners for completion of the clinical development, regulatory approval, and commercialization, enabling medical scientists to develop new drugs in the fields of dermatology, ophthalmology and respiratory and target new routes of administration, expansion of indications and improved delivery.

Contact Information

Website
www.hovione.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Lindenstrasse 14
  • 6340 Baar
  • Switzerland
Primary Industry
BPO/Outsource Services
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • Lindenstrasse 14
  • 6340 Baar
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hovione Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hovione‘s full profile, request access.

Request a free trial

Hovione Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a contract drug substance manufacturing company intended for making disease treatment faster and more afford
BPO/Outsource Services
Baar, Switzerland
2,600 As of 2026

Woodbury, MN
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hovione Competitors (30)

One of Hovione’s 30 competitors is Kindeva Drug Delivery, a Private Equity-Backed company based in Woodbury, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kindeva Drug Delivery Private Equity-Backed Woodbury, MN
Patheon Formerly PE-Backed Waltham, MA
Bend Bioscience (Formerly CoreRx) Private Equity-Backed Clearwater, FL
PCI Pharma Services Private Equity-Backed Philadelphia, PA
Catalent Private Equity-Backed Tampa, FL
You’re viewing 5 of 30 competitors. Get the full list »

Hovione Patents

Hovione Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026163139-A1 Β-lactoglobulin for use as antiviral agent Pending 31-Jan-2025
WO-2026159667-A1 Synthetic sugars as enablers for viscosity reduction of highly concentrated biological molecules Pending 24-Jan-2025
WO-2026082944-A1 High-density composite active particles comprising beta-lactoglobulin and api, compositions comprising same, and methods for the manufacture thereof Pending 17-Oct-2024
WO-2026013055-A1 Methods and systems for preparing feed solutions for spray drying Pending 09-Jul-2024
WO-2025253015-A1 A pharmaceutical product collection device, method, and pharmaceutical manufacturing system Pending 07-Jun-2024 B65B57/20
To view Hovione’s complete patent history, request access »

Hovione Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hovione Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hovione‘s full profile, request access.

Request a free trial

Hovione Investments & Acquisitions (5)

Hovione’s most recent deal was a Joint Venture with ViSync Technologies. The deal was made on 19-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ViSync Technologies 19-Sep-2024 Joint Venture Drug Delivery
ExtremoChem 16-Nov-2023 Merger/Acquisition Specialty Chemicals
Oxular 19-Jul-2016 Early Stage VC Drug Discovery
Hovione (Formulation Plant) 19-Oct-2015 Corporate Asset Purchase Buildings and Property
Pfizer (Loughbeg API Site) 11-Dec-2008 Corporate Asset Purchase Buildings and Property
To view Hovione’s complete investments and acquisitions history, request access »

Hovione Exits (1)

Hovione’s most recent exit was on 19-Jul-2016 from Oxular. The exit was categorized as with 6 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Oxular 19-Jul-2016 Completed
  • 6 buyers
To view Hovione’s complete exits history, request access »

Hovione FAQs

  • When was Hovione founded?

    Hovione was founded in 1959.

  • Where is Hovione headquartered?

    Hovione is headquartered in Baar, Switzerland.

  • What is the size of Hovione?

    Hovione has 2,600 total employees.

  • What industry is Hovione in?

    Hovione’s primary industry is BPO/Outsource Services.

  • Is Hovione a private or public company?

    Hovione is a Private company.

  • What is Hovione’s current revenue?

    The current revenue for Hovione is .

  • Who are Hovione’s investors?

    Explorer Investments has invested in Hovione.

  • Who are Hovione’s competitors?

    Kindeva Drug Delivery, Patheon, Bend Bioscience (Formerly CoreRx), PCI Pharma Services, and Catalent are some of the 30 competitors of Hovione.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process